Cariprazine in the treatment of psychosis with comorbid cannabis use: A case report

Abstract

Past literature highlights that cannabis use increase the risk of developing psychotic disorder. In this case report, the authors describe the employment of cariprazine in the treatment of a young adult male affected by psychosis and co-morbid cannabis use. The pharmacodynamic properties of cariprazine suggest that this molecule interacts in the reward system improving both craving and negative symptoms of psychosis. To the best of author's knowledge no data has been published yet about the safety and the efficacy of cariprazine treatment of psychotic patients with cannabis use.